Legacy, a Cambridge, Mass.-based male fertility startup based out of Harvard Innovation Labs, raised $1.5m in funding.
The round was led by Bain Capital Ventures.
The company intends to use the funds to expand its suite of male fertility offerings to include sperm analysis, improvement, and cryogenic storage.
Led by CEO Khaled Kteily, Legacy enables men to test, improve and freeze their sperm, without visiting a clinic or meeting with a doctor. Clients have the Legacy kit shipped to home before sending it back to one of Legacy’s partner clinics for clinical-level analysis.
Within 24 hours, every client receives a full fertility report that analyzes volume, count, concentration, motility, and morphology, as well as the option to freeze their deposit at cryogenic storage facilities.